The current updated recommended guidelines for preventive care and follow up in Hematopoietic Cell Transplant (HCT) focus on the risks faced by HCT survivors (autologous and allogeneic) who have survived 6 months or more post- transplant (Majhail et al., 2012). Adherence to care guidelines for HCT survivors has many challenges because of the lack of a standardized patient care plans specific to HCT survivors (Majhil et al., 2012). Also, long-term HCT survivors may not always return to their transplant center for care, but instead seek health care at other outpatient facilities that are not familiar with the recommended guidelines. There are few studies that examine the adherence to guidelines in HCT survivors. …show more content…
Beeken, Eiser & Dalley (2011) reported that patients feeling optimism about treatment, having social support to help cope, having social comparisons with others who have received HCT, changing their expectations (accepting that things will be different and adapting) and setting goals to create a sense of achievement were important in managing threats to their HRQOL. A study completed by Cohen et al. (2012), identified that the type of treatment a preparatory regimen are the most important factors that influence post-HCT symptoms and HRQOL. The data showed that allogeneic transplant patients with myeloablative regimens showed more sleep disturbances and poorer HRQOL than autologous recipients. Also, it showed that patients with good functional status had a higher HRQOL and reported less symptoms, and patients with GVHD reported more severe symptoms than those without GVHD. They also determined that ethnicity was not a significant factor in symptom severity or HRQOL. However, in a study completed by Brown-lannuzzi et al. (2014) found that higher socioeconomic status (SES) was associated with lower depressive symptoms, less generalized distress, and better overall HRQOL eluding that a person’s relative rank in society has important health consequences and must be taken into consideration by